Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2000
10/19/2000WO2000061737A2 Production of attenuated negative stranded rna virus vaccines
10/19/2000WO2000061736A2 Recombinant and mutant marek's disease virus
10/19/2000WO2000061735A1 Modification of plant storage reserves
10/19/2000WO2000061733A1 Xylose isomerase with improved properties
10/19/2000WO2000061731A2 Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
10/19/2000WO2000061730A1 Glucose dehydrogenase
10/19/2000WO2000061729A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
10/19/2000WO2000061728A2 Human elastase i
10/19/2000WO2000061727A2 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use
10/19/2000WO2000061725A1 Method of purifying heterologous proteins
10/19/2000WO2000061724A2 Anti-bacterial vaccine compositions
10/19/2000WO2000061723A1 L-amino acid-producing bacteria and process for producing l-amino acid
10/19/2000WO2000061637A1 Erythropoietin receptor antibodies
10/19/2000WO2000061635A2 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment
10/19/2000WO2000061634A2 Ecotin-variant modulators of serine proteases
10/19/2000WO2000061629A1 49 human secreted proteins
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061626A1 49 human secreted proteins
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061624A1 48 human secreted proteins
10/19/2000WO2000061623A1 62 human secreted proteins
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061617A2 Transiently immortalized cells for use in gene therapy
10/19/2000WO2000061616A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2000WO2000061615A2 Homologs of mar-binding filament-like protein 1 (mfp1)
10/19/2000WO2000061614A2 Uncoupling proteins
10/19/2000WO2000061612A2 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000WO2000061611A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
10/19/2000WO2000061610A2 Prostate-restricted gene 30p3c8 expressed in prostate cancer
10/19/2000WO2000061606A1 Novel human voltage-gated potassium channel
10/19/2000WO2000061602A1 Antisense oligonucleotide modulation of stat3 expression
10/19/2000WO2000061601A1 ANTISENSE MODULATION OF G-ALPHA-i1 EXPRESSION
10/19/2000WO2000061600A1 Antisense modulation of smad3 expression
10/19/2000WO2000061599A1 Antisense modulation of microtubule-associated protein 4 expression
10/19/2000WO2000061597A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061595A1 The novel antisense-oligos with better stability and antisense effect
10/19/2000WO2000061525A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
10/19/2000WO2000061230A2 Estrogen receptors-beta antagonism and bone diseases
10/19/2000WO2000061198A1 Method of producing probe arrays for biological materials using fine particles
10/19/2000WO2000061193A1 Antisense modulation of mdmx expression
10/19/2000WO2000061190A2 Treatment of intracellular infection
10/19/2000WO2000061180A2 Products and methods for treating ptp lar related diseases
10/19/2000WO2000061171A2 Uses of mammalian ox2 protein and related reagents
10/19/2000WO2000061150A1 Antisense modulation of fas mediated signaling
10/19/2000WO2000060945A1 SOLUBLE RECOMBINANT ENDOSTATIN AND METHOD OF MAKING SAME FROM $i(STREPTOMYCES SP)
10/19/2000WO2000060933A1 Pkc induced targets
10/19/2000WO2000060932A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1
10/19/2000WO2000060919A2 Anchored strand displacement amplification on an electronically addressable microchip
10/19/2000WO2000039280A8 Leukocyte-derived interferon preparations
10/19/2000WO2000037682A8 Method for augmenting expression of a foreign gene
10/19/2000WO2000037641A3 Vascular endothelial growth factor-x
10/19/2000WO2000036093A3 Intein-mediated cyclization of peptides
10/19/2000WO2000034780A3 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
10/19/2000WO2000034485A3 Beta-1,3-galactosyltransferase homologs
10/19/2000WO2000034308A3 Protein transduction system and methods of use thereof
10/19/2000WO2000033872A3 Method of and compositions for immunization with the pseudomonas v antigen
10/19/2000WO2000032809A3 Cloning and copying on surfaces
10/19/2000WO2000032793A3 Plant cell derived diacylglycerol acyltransferases
10/19/2000WO2000032778A3 Methods and compositions for inhibiting neoplastic cell growth
10/19/2000WO2000032769A3 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
10/19/2000WO2000031294A3 Method for identifying cytosine methylation patterns in genomic dna
10/19/2000WO2000031279A3 Producing antimicrobial cationic peptides as fusion proteins
10/19/2000WO2000031264A3 Testis-specific cystatin-like protein cystatin t
10/19/2000WO2000031125A3 REGULATORY PROTEIN pKe#83 FROM HUMAN KERATINOCYTES
10/19/2000WO2000029551A3 Cells, culture methods, and their use in autologous transplantation therapy
10/19/2000WO2000029550A9 Low oxygen culturing of central nervous system progenitor cells
10/19/2000WO2000028008B1 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase
10/19/2000WO2000026368A9 Therapeutic antiangiogenic endostatin compositions
10/19/2000WO2000025922A3 Multi-well microfiltration apparatus
10/19/2000WO2000022114A9 PRODUCTION OF ssDNA $i(IN VIVO)
10/19/2000WO2000019883A9 Compositions and methods of disease diagnosis and therapy
10/19/2000WO2000013702A9 Use of an angiogenic factor for the treatment of microvascular angiopathies
10/19/2000WO2000012732A3 Organelle targeting sequences
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000WO2000004155A9 Compositions and methods for enhancing disease resistance in plants
10/19/2000WO1999067381A9 Treatment of staphylococcus infections
10/19/2000WO1999063088A8 Membrane-bound proteins and nucleic acids encoding the same
10/19/2000DE19916929A1 New oligonucleotide primers, useful for amplifying human telomerase RNA for diagnosis, prognosis and monitoring of cancer
10/19/2000DE19916534A1 RNA-Isolierungs-Kit RNA isolation kit
10/19/2000DE19916417A1 New amyloid-specific aptamer, useful for diagnosis and/or treatment of e.g. Alzheimer's disease, is stabilized against nucleases
10/19/2000DE19915938A1 Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung Production of pancreatic procarboxypeptidase B isoforms and its muteins and their use
10/19/2000DE19915485A1 Therapie der Herzinsuffizienz Treatment of heart failure
10/19/2000DE19914808A1 Informationstragende Polymere An information-carrying polymers
10/19/2000CA2815763A1 Anti-bacterial vaccine compositions
10/19/2000CA2815566A1 Pasteurellaceae bacteria comprising a mutated virulence gene and an anti-bacterial vaccine prepared therefrom
10/19/2000CA2760534A1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000CA2403209A1 Synthesis of biologically active compounds in cells
10/19/2000CA2372120A1 Transgenic plants containing altered levels of sterol compounds and tocopherols
10/19/2000CA2372078A1 Treatment of intracellular infection
10/19/2000CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000CA2371941A1 Method of purifying heterologous proteins
10/19/2000CA2371223A1 49 human secreted proteins
10/19/2000CA2371172A1 50 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370562A1 49 human secreted proteins
10/19/2000CA2370523A1 49 human secreted proteins
1 ... 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177 3178 3179 3180 3181 3182 3183 3184 3185 3186 3187 3188 ... 4023